Short interest in Summit Therapeutics Inc (NASDAQ:SMMT) increased during the last reporting period, rising from 15.99M to 16.84M. This put 14.17% of the company's publicly available shares short.

Short interest for Summit Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Summit Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 1.59M shares traded per day, it would take 10.62 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.